Related Experiment Videos
Structural characterization of the BCR gene product
1Howard Hughes Medical Institute, University of California, Los Angeles 90024-1570.
Oncogene
|May 1, 1989
Summary
Researchers identified the normal BCR gene product as a 160-kilodalton phosphoprotein. Overproduction of this protein in NIH3T3 cells showed kinase activity but no morphological transformation, offering insights into Chronic myelogenous leukemia (CML) pathogenesis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Chronic myelogenous leukemia (CML) is linked to the BCR-ABL fusion gene.
- The BCR-ABL protein (P210) is a hallmark of CML.
- Understanding the normal BCR gene product is crucial for CML research.
Purpose of the Study:
- To identify and characterize the normal BCR gene product.
- To investigate the functional consequences of normal BCR protein overproduction.
Main Methods:
- Used BCR cDNA clones to create retroviral and bacterial transcription vectors.
- Performed in vitro translation and immunoprecipitation.
- Analyzed NIH3T3 cell lines expressing BCR retroviruses.
Main Results:
- Identified the normal BCR gene product as a 160-kilodalton phosphoprotein.
- Overexpression of BCR RNA led to a 2-10 fold increase in BCR protein levels.
- Observed associated kinase activity but no morphological transformation in NIH3T3 cells.
Conclusions:
- The normal BCR protein is a phosphoprotein with kinase activity.
- BCR protein levels are regulated by its 5' and 3' untranslated regions.
- BCR overproduction alone does not induce cellular transformation.